Abstract
We evaluated the efficiacy of oral diypridamole therapy for the normalization of angiographically determined slow coronary artery flow. Diypridamole, which has dilatator properties on coronary microvessels, proved to be an effective treatment in most patients with slow coronary artery flow.
MeSH terms
-
Administration, Oral
-
Adult
-
Blood Flow Velocity / drug effects*
-
Contrast Media
-
Coronary Angiography*
-
Coronary Circulation / drug effects*
-
Dipyridamole / administration & dosage*
-
Dipyridamole / therapeutic use
-
Female
-
Humans
-
Iohexol / analogs & derivatives*
-
Male
-
Middle Aged
-
Vasodilator Agents / administration & dosage*
-
Vasodilator Agents / therapeutic use
Substances
-
Contrast Media
-
Vasodilator Agents
-
Iohexol
-
Dipyridamole
-
iopromide